StockWatch
·

RELAXO FOOTWEARS LTD.-$ Q4 FY25 Results

RELAXOQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue695.154.2%
Total Income703.244.4%
Expenditure627.880.2%
PBT75.3668.9%
Net Profit56.2270.3%
OPM16.12%17.29pp
NPM7.99%3.09pp
EPS2.2671.2%
View full financials

Relaxo Footwears Ltd Reports FY25 Revenue at Rs. 2,790 crores, EBITDA at Rs. 382 crores, and PAT at Rs. 170 Crores

09 May 2025 · 9 May 2025, 07:41 pm

Summary

Relaxo Footwears Limited, India's largest footwear manufacturing company, has declared its Audited Financial Results for the Quarter 4 and Full Year ended 31st March 2025. The company's revenue for FY25 stood at Rs. 2,790 crores, a slight decrease from the previous year. EBITDA for FY25 was at Rs. 382 crores, with an EBITDA margin of 13.7%. The company's Profit After Tax for FY25 was Rs. 170 Crores, with a PAT margin of 6.1%. The Q4 FY25 results showed a revenue of Rs. 695 crores, a slight increase from the previous quarter but a decrease from Q4 FY24. The company is optimistic about the future, with key initiatives in place to drive profitable growth.

Key Highlights

  1. 1

    Revenue for FY25 at Rs. 2,790 crores

  2. 2

    EBITDA for FY25 at Rs. 382 crores with a margin of 13.7%

  3. 3

    Profit After Tax for FY25 at Rs. 170 Crores with a PAT margin of 6.1%

  4. 4

    Q4 FY25 revenue at Rs. 695 crores

  5. 5

    Company implementing strategies for profitable growth in the coming years

Management Comments

M

Mr. Ramesh Kumar Dua

FY25 was a year of consolidation for Relaxo. While our topline was impacted by muted demand in the mid-range footwear segment and internal restructuring of our distribution model, these were strategic interventions aimed at setting the business on a stronger, more agile footing. We believe that this sets us up to grow profitably in the coming years. As it stands, we firmly believe this is the bottom and while there are still some moving parts in work in the next few quarters, the trajectory will trend upwards from here. We believe the full effect of the restructuring and other investments will start showing up from the second half of fiscal FY 26. Key initiatives implemented by the company include optimising our distributor and retailer network through the “Relaxo Parivaar” app, pivoting to “Brand As Seller” model & launching new product range for the e-commerce channel, establishing a tech-enabled warehouse for the shoe division, and enhancing our supply chain operations. Looking ahead at FY 26, our priority is to drive profitable growth. While the topline is expected to remain steady with a potential upward bias, our efforts will be directed toward EBITDA enhancement, led by operational efficiencies, digital initiatives, and a sharper product focus.

Informational and educational content only. Not investment advice.